All
the news

Filtre

NeoSickle makes a successful transition to the new IVD regulations

16/10/23

Biomaneo's first IVDR CE-certified product

Detection of a new case of Hb Wanjiang.

11/07/23

This discovery was the subject of a new publication

Biomaneo becomes a subsidiary of Shimadzu Corporation

09/06/23

Biomaneo becomes a wholly-owned subsidiary of Shimadzu Corporation (Kyoto, Japan)

4th Global Congress on Sickle Cell Disease

14/06/22

Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18. 

Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team

31/08/21

A key step for the marketing of its In Vitro Diagnostic Devices (IVDD) and in the transition to the new 2017/746 regulation.

New NeoSickle installation

26/08/21

With this second installation, 80% of French samples are now analysed using the NeoSickle solution.